Seamless technology transfer from lab bench to commercial production ensures consistent quality at every scale.
Robust route design incorporates ICH Q11 guidelines, simplifying FDA/EMA filing for your drug substance applications.
We specialize in ultra-low temperature synthesis down to -78°C, enabling delicate transformations that preserve thermally sensitive intermediates. Our cryogenic infrastructure supports reactions involving organolithium reagents, enolate chemistry, and stereoselective additions that demand precise thermal control for optimal yield and selectivity.
Route-dependent intermediates are specific compounds whose availability, quality, or cost is directly tied to the synthetic pathway chosen for API manufacturing. Unlike generic building blocks, these intermediates require precise process conditions and specialized expertise to produce consistently.
Your chosen route impacts patent freedom, regulatory approval timeline, and overall COGS. We help identify and develop route-specific intermediates that optimize yield, minimize impurities, and ensure long-term supply security for your commercial manufacturing needs.
Absolutely. We analyze your current process, identify critical intermediates, and develop robust manufacturing methods tailored to your specifications. Our goal is seamless integration with your downstream operations without disrupting established workflows.
B608, #25 Shenbin Rd, Minhang District, Shanghai, China
English
